Suppr超能文献

NCCN 指南®洞察:卵巢癌,第 3.2022 版。

NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.

机构信息

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Vanderbilt-Ingram Cancer Center.

出版信息

J Natl Compr Canc Netw. 2022 Sep;20(9):972-980. doi: 10.6004/jnccn.2022.0047.

Abstract

Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States, with less than half of patients living >5 years following diagnosis. The NCCN Guidelines for Ovarian Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with ovarian, fallopian tube, and primary peritoneal cancers. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including revised guidance on alternative chemotherapy regimens for patients with advanced age and/or comorbidities, a new algorithm for recurrent low-grade serous carcinoma based on developing research and novel therapeutic agents, and updated language regarding tumor molecular analysis applications in ovarian cancer.

摘要

上皮性卵巢癌是美国妇科癌症死亡的主要原因,不到一半的患者在诊断后能存活超过 5 年。NCCN 卵巢癌临床实践指南为卵巢癌、输卵管癌和原发性腹膜癌患者的诊断、评估、治疗和随访提供了建议。这些 NCCN 指南见解总结了指南最近重要更新背后的小组讨论,包括针对高龄和/或合并症患者的替代化疗方案的修订指南、基于不断发展的研究和新型治疗药物的复发性低级别浆液性癌新算法,以及关于卵巢癌肿瘤分子分析应用的更新语言。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验